GMED - Globus Medical - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GMED is currently covered by 13 analysts with an average price target of $95.15. This is a potential upside of $10.24 (12.06%) from yesterday's end of day stock price of $84.91.

Globus Medical's activity chart (see below) currently has 198 price targets and 179 ratings on display. The stock rating distribution of GMED is 46.67% BUY, 50% HOLD and 3.33% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 86.78% with an average time for these price targets to be met of 224.68 days.

Highest price target for GMED is $100, Lowest price target is $78, average price target is $95.15.

Most recent stock forecast was given by DAVID SAXON from NEEDHAM on 07-Nov-2024. First documented stock forecast 17-Jun-2013.

Currently out of the existing stock ratings of GMED, 28 are a BUY (46.67%), 30 are a HOLD (50%), 2 are a SELL (3.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

15 days ago
(07-Nov-2024)

2/3 (66.67%)

$10.44 (17.24%)

115

Buy

$88

$6.9 (8.51%)

$78

16 days ago
(06-Nov-2024)

8/9 (88.89%)

$7.85 (9.79%)

266

Buy

$100

$18.9 (23.30%)

$75

16 days ago
(06-Nov-2024)

8/12 (66.67%)

$19.85 (24.77%)

268

Buy

$100

$18.9 (23.30%)

$80

16 days ago
(06-Nov-2024)

14/19 (73.68%)

$19.85 (24.77%)

224

Buy

$92

$10.9 (13.44%)

$70

16 days ago
(06-Nov-2024)

7/8 (87.5%)

$11.85 (14.78%)

127

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GMED (Globus Medical) average time for price targets to be met?

On average it took 224.68 days on average for the stock forecasts to be realized with a an average price target met ratio 86.78

Which analyst has the current highest performing score on GMED (Globus Medical) with a proven track record?

SANJIT SINGH

Which analyst has the most public recommendations on GMED (Globus Medical)?

Sanjit Singh works at MORGAN STANLEY and has 26 price targets and 8 ratings on GMED

Which analyst is the currently most bullish on GMED (Globus Medical)?

Matt O'brien with highest potential upside - $18.9

Which analyst is the currently most reserved on GMED (Globus Medical)?

Steven Lichtman with lowest potential downside - -$58.1

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?